Look out, GSK. Pfizer has its adult RSV vaccine approval and is raring to launch
Fierce Pharma
JUNE 1, 2023
About a month after GSK won the world's first approval for a respiratory syncytial virus (RSV) vaccine, rival Pfizer has followed suit. After winning FDA approvals one month apart, Pfizer and GSK are set to launch competing RSV vaccines this fall.
281 
Let's personalize your content